Trial Profile
Effect of olmesartan on beta-cell function and diabetic angiopathy in type 2 diabeteic patients with hypertension
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Olmesartan medoxomil (Primary) ; Amlodipine
- Indications Diabetic angiopathies; Hypertension
- Focus Therapeutic Use
- 28 Oct 2011 New trial record